地址：中国 广州市 黄埔大道西601号 版权所有©暨南大学
限定内容
主题
- 33,520 篇 白血病
- 16,093 篇 贫血
- 13,818 篇 多发性骨髓瘤
- 9,637 篇 治疗
- 9,535 篇 血栓形成
- 7,867 篇 缺铁性贫血
- 7,657 篇 儿童
- 7,500 篇 再生障碍性贫血
- 7,490 篇 诊断
- 5,773 篇 护理
- 5,532 篇 急性白血病
- 5,234 篇 造血干细胞移植
- 4,695 篇 地中海贫血
- 4,646 篇 造血干细胞
- 4,541 篇 mds
- 4,481 篇 淋巴瘤
- 4,410 篇 血小板聚集
- 4,336 篇 血癌
- 3,963 篇 dic
- 3,824 篇 预后
机构
- 1,414 篇 苏州大学附属第一...
- 1,232 篇 北京大学人民医院
- 1,168 篇 解放军总医院
- 952 篇 重庆医科大学
- 933 篇 苏州大学
- 924 篇 郑州大学第一附属...
- 740 篇 华中科技大学同济...
- 689 篇 四川大学华西医院
- 589 篇 山西医科大学
- 562 篇 广西医科大学第一...
- 547 篇 福建医科大学
- 527 篇 河北医科大学第二...
- 527 篇 华中科技大学同济...
- 523 篇 浙江大学医学院附...
- 511 篇 中国医科大学
- 503 篇 univ texas md an...
- 484 篇 暨南大学
- 476 篇 华中科技大学
- 460 篇 首都医科大学附属...
- 435 篇 中山大学附属第一...
文献订阅
- Combination of Decitabine and Etoposide Is Highly Effective in Treating p53-Mutated MDS/AML Via Activating Notch Signaling
- Fudan Univ Huadong Hosp Dept Hematol Shanghai Peoples R ChinaFudan Univ Huadong Hosp Shanghai Peoples R ChinaZhejiang Univ Sch Med Affiliated Hosp 1 Dept Hematol Hangzhou Peoples R ChinaZhejiang Univ Affiliated Hosp 1 Coll Med Hangzhou Peoples R ChinaShanghai Jiao Tong Univ Sch Med Dept Hematol & OncolShanghai Childrens Med Ctr Key Lab Pediat Hematol & OncolMinist Hlth China Shanghai Peoples R China
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Deregulation of HLA-Class I and Class II Genes in Chip, MDS, and Acute Leukemia and Similarity between Chip and MDS in HLA Profile
- Genom Testing Cooperat Irvine CA USAHackensack Meridian Sch Med Hackensack NJ USAMedStar Georgetown Univ Hosp Lombardi Comprehens Canc Ctr Washington DC USAHackensack Meridian Hlth John Theurer Canc Ctr Hackensack NJ USAHackensack Univ Med Ctr Hackensack NJ USAHackensack Meridian Hlth John Theurer Canc Ctr Lymphoma Div Hackensack NJ USA
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results
- DKFZ Hector Canc Inst Dept Personalised Oncol Heidelberg GermanyDept Personalised Oncol Mannheim GermanyHannover Med Sch Hannover GermanyUniv Hosp Frankfurt Bielsko Biala PolandUniv Iowa Hosp & Clin Iowa City IA USAUniv Hosp Ulm Ulm GermanyAzienda Osped Univ Parma Hematol Unit Parma ItalyAzienda Osped Univ Parma BMT Ctr Parma ItalyOsped V Fazzi Haematol Lecce ItalyUniv Genoa Dept Internal Med DiMI Clin Hematol Genoa ItalyASO S Croce & Carle Cuneo ItalyUniv Med Ctr Mannheim DKFZ Hector Canc Inst Hamburg GermanyUniv Hosp Hamburg Eppendorf Hamburg GermanyUniv Med Ctr Mannheim DKFZ Hector Canc Inst Dept Personalized Oncol Mannheim GermanyGerman Canc Res Ctr Dept Personalized Oncol Heidelberg GermanyBerGenBio ASA Translat Res Bergen NorwayBerGenBio Ltd Oxford EnglandUniv Texas MD Anderson Canc Ctr Houston TX USAUniv Bergen Dept Clin Sci Ctr Canc Biomarkers CCBIO Bergen Norway
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Development of Oral Azacitidine with Cedazuridine for Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms ( MPN) Including CMML (Chronic Myelomonocytic Leukemia) By Targeting Pharmacokinetic AUC Equivalence Vs Subcutaneous Azacitidine
- Univ Texas MD Anderson Canc Ctr Houston TX 77030 USAHackensack Med Ctr John Thuerer Canc Ctr Hackensack NJ 07604 USAFred Hutchinson Canc Ctr Seattle WA USARoswell Pk Comprehens Canc Ctr Buffalo NY USANYU Langone Hlth Perlmutter Canc Ctr New York NY USAWeill Cornell Med New York NY USANew York Presbyterian Hosp New York NY USAOregon Oncol Specialists Salem OR USAAstex Pharmaceut Inc Pleasanton CA USAVanderbilt Univ Sch Med Vanderbilt Ingram Canc Ctr Nashville TN USA
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study
- Johns Hopkins Univ Baltimore MD USAEmmes Co Rockville MD USAWashington Univ St Louis St Louis MO USAH Lee Moffitt Canc Ctr & Res Inst Dept Malignant Hematol Tampa FL USADana Farber Canc Inst Boston MA USAFred Hutchinson Canc Res Ctr Seattle WA USAIHA Hematol Oncol Consultants Ypsilanti MI USAIllinois CancerCare Peoria IL USANCI Canc Prevent Div Rockville MD USAMed Coll Wisconsin Milwaukee WI USAUniv Calif San Diego San Diego CA USAWashington Univ Div Oncol Dept Med Sch Med St Louis MO USAEmmes Co LLC Rockville MD USANHLBI Div Blood Dis & Resources Bethesda MD USAUniv Miami Sylvester Comprehens Canc Ctr Miami FL USA
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Efficacy and Safety of Luspatercept plus /- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS- RS): A French Multicenter Prospective Real-Life Registry
- Toulouse Univ Hosp Toulouse FranceCtr Hosp Reg Univ CHRU Dept Hematol Vandoeuvre Les Nancy FranceCHRU Nancy Vandoeuvre Les Nancy FrancePoitier Univ Hosp Poitiers FranceSt Louis Hosp AP HP Paris FranceHop St Louis Paris FranceCH METZ Metz FranceCtr Leon Berard Lyon 08 FranceCH Lorient Quimper FranceCtr Henri Becquerel Rouen FranceAngers Univ Hosp Dept Clin Hematol Angers FranceCHU Besancon Dept Clin Hematol Besancon FranceAlbi Hop Albi FranceCastres Hosp Castres FranceBordeaux Univ Hosp Pessac FranceCHU Grenoble Grenoble 9 FranceHosp Civils Lyon Lyon FranceCtr Hosp Gen Avignon Serv Oncohematol Avignon FranceHop Cochin AP HP Paris FranceCHR Metz Thionville Ars Laquenexy FranceServ Hematol & Therapie Cellulaire Tours FranceCH Perigueux Perigueux FranceSt Louis Hosp Paris FranceHop Cochin Paris FranceHop St Louis Hematol Dept Paris FranceHop St Louis Grp Francophone Myelodysplasies Paris France
- 来源 ScienceCitationIndex... 详细信息
- Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
- Kuwait Canc control Ctr Kuwait KuwaitNatl Ctr Canc Care & Res Hematol BMT Doha QatarHamad Univ Ar Rayyan QatarNatl Guard Hlth Affairs Princess Noorah Oncol Ctr King Abdulaziz Med City Western Reg Jeddah Saudi ArabiaMinist Natl Guard Hlth Affairs Dept Adult Hematol & Stem Cell Transplantat Princess Noorah Oncol Ctr Jeddah Saudi ArabiaSheikh Shakhbout Med Ctr Abu Dhabi U Arab EmiratesKuwait Canc Ctr Shuwaikh Kuwait
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Preclinical and Clinical Evidence for Erythroid-Stimulating Activity of RVU120 CDK8/19 Inhibitor in AML and MDS
- Ryvu Therapeut Buccinasco ItalyInst Hematol & Transfus Med Warsaw PolandMed Univ Gdansk Dept Haematol & Transplantol Gdansk PolandWashington Univ Sch Med St Louis MO USARyvu Therapeut Krakow PolandUniv Childrens Hosp Cracow Krakow PolandMed Univ Gdansk Dept Hematol & Transplantol Gdansk Poland
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Five-Year Follow up Results of Phase II Clinical Trial Evaluating Ruxolitinib (RUX) and Azacitidine (AZA) Combination Therapy in Patients (pts) with Myelodysplastic Syndrome/Myeloproliferative Neoplasms (MDS/MPNs)
- Univ Texas MD Anderson Canc Ctr Div Canc Med Houston TX USAUniv Texas MD Anderson Canc Ctr Dept Leukemia Houston TX USAMD Anderson Canc Ctr Houston TX USAMD Anderson Canc Ctr Dept Leukemia Houston TX USAUniv Texas MD Anderson Canc Ctr Houston TX USA
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
- Kme-0584, a Highly Potent IRAK1/IRAK4/panFLT3 Inhibitor, Is a Promising Clinical Candidate for Hypomethylating Agent Plus Venetoclax Resistant AML/MDS Patients
- Kurome Therapeut Inc Cincinnati OH USANatl Ctr Adv Translat Sci Natl Inst Hlth Div Preclin Innovat Rockville MD USANatl Ctr Adv Translat Sci Natl Inst Hlth Div Preclin Innovat Chem Technol Rockville MD USACincinnati Childrens Hosp Med Ctr Div Expt Hematol & Canc Biol Cincinnati OH USA
-
来源
ScienceCitationIndex...
Elsevier ScienceDire...
详细信息
粤公网安备 44010602001461号
